{
    "nctId": "NCT01814397",
    "briefTitle": "Pilot Study to Evaluate the Effect of Aromatase Inhibitor Therapy on Pain Threshold in Breast Cancer Patients",
    "officialTitle": "Prospective Pilot Study to Determine the Effect of Aromatase Inhibitor-induced Estrogen Depletion on Evoked Pain Threshold and Psychosocial Factors in Breast Cancer Patients",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer, Pain, Arthralgia",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 50,
    "primaryOutcomeMeasure": "Mean Pain50 Assessed at Baseline, 3 Months and 6 Months",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Female gender\n* Postmenopausal, age 21 or greater\n* Stage 0-III estrogen receptor and/or progesterone receptor positive breast cancer who will be receiving a standard dose of letrozole, anastrozole, or exemestane\n* Performance status 0-2\n* Willing to sign the consent form\n\nExclusion Criteria:\n\n* Average pain \\>=8/10 over the past 24 hours\n* Peripheral sensory neuropathy grade 2 or higher\n* Personal history of schizophrenia, or suicidal ideation or attempt within the past 2 years\n* Thumbnail abnormalities on either hand that are likely to alter pain perception during testing",
    "sex": "FEMALE",
    "minimumAge": "21 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}